Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
15.9M
-
Shares change
-
-113K
-
Total reported value, excl. options
-
$21.7M
-
Value change
-
-$164K
-
Number of buys
-
10
-
Number of sells
-
-15
-
Price
-
$1.37
Significant Holders of NextCure, Inc. - Common Stock (NXTC) as of Q3 2024
50 filings reported holding NXTC - NextCure, Inc. - Common Stock as of Q3 2024.
NextCure, Inc. - Common Stock (NXTC) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.9M shares
of 28M outstanding shares and own 56.6% of the company stock.
Largest 10 shareholders include Sofinnova Investments, Inc. (2.67M shares), Logos Global Management LP (2.5M shares), Affinity Asset Advisors, LLC (2.3M shares), ORBIMED ADVISORS LLC (1.14M shares), VANGUARD GROUP INC (987K shares), BlackRock, Inc. (730K shares), TANG CAPITAL MANAGEMENT LLC (652K shares), Cable Car Capital LLC (616K shares), Long Focus Capital Management, LLC (556K shares), and ACADIAN ASSET MANAGEMENT LLC (488K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.